Cart
sales@molnova.com
EG1
CAS No. 693241-54-2
EG1 ( —— )
Catalog No. M24706 CAS No. 693241-54-2
EG1, a novel specific inhibitor of Pax2 transcription activation, targets the DNA binding domain and inhibits embryonic kidney development.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 5MG | 133 | In Stock |
|
| 10MG | 203 | In Stock |
|
| 25MG | 410 | In Stock |
|
| 50MG | 605 | In Stock |
|
| 100MG | 852 | In Stock |
|
| 500MG | 1701 | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameEG1
-
NoteResearch use only, not for human use.
-
Brief DescriptionEG1, a novel specific inhibitor of Pax2 transcription activation, targets the DNA binding domain and inhibits embryonic kidney development.
-
DescriptionEG1, a novel specific inhibitor of Pax2 transcription activation, targets the DNA binding domain and inhibits embryonic kidney development.
-
Synonyms——
-
PathwayOthers
-
TargetOther Targets
-
RecptorPax2
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number693241-54-2
-
Formula Weight390.4
-
Molecular FormulaC22H18N2O5
-
Purity>98% (HPLC)
-
SolubilityDMSO:70mg/ml(179.31mM; need ultrasonic)
-
SMILESCOc(cccc1)c1C(Nc(cc1)ccc1C(Nc(cccc1)c1C(O)=O)=O)=O
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.Smith CB, Phillips T, Smith TJ. Using the New ASCO Clinical Practice Guideline for Palliative Care Concurrent With Oncology Care Using the TEAM Approach. Am Soc Clin Oncol Educ Book. 2017;37:714-723. doi: 10.14694/EDBK_175474. PubMed PMID: 28561696.
molnova catalog
related products
-
Glycinamide Hydrochl...
Glycinamide Hydrochloride is a glycine pro-drug.
-
Malvidin-3-glucoside...
Malvidin-3-glucoside chloride (Malvidin-3-O-glucoside chloride), a major wine anthocyanin, is effective in promoting resilience against stress by modulating brain synaptic plasticity and peripheral inflammation.
-
Pro-xylane
Pro-xylane (Hydroxypropyl tetrahydropyrantriol) is a biologically active C-glycoside in aqueous media, acts as an activator of glycosaminoglycans (GAGs) biosynthesis.
